Establishment of a new approach for quality evaluation of Pseudobulbus Cremastrae seu Pleiones (Shancigu) based on multicomponent analysis and anti-liver cancer pharmacological effects

Establishment of a new approach for quality evaluation of Pseudobulbus Cremastrae seu Pleiones (Shancigu) based on multicomponent analysis and anti-liver cancer pharmacological effects

BackgroundPseudobulbus Cremastrae seu Pleiones (Shancigu), a traditional Chinese medicine (TCM), has been extensively used in clinical practice for the treatment of various tumors, particularly liver cancer. Shancigu is classified into two commercial specifications—“Maocigu” and “Bingqiuzi”—which ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxin Cao, Zhuangzhuang Hao, Mengmeng Liu, Jingwen Xue, Yuqing Wang, Tingyue Jiang, Ge Zhang, Wenxin Fan, ChunGuo Wang, Jinli Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
Pseudobulbus Cremastrae seu Pleiones
different commercial specifications
spectrum–effect relationship
serum pharmacochemistry
anti-liver cancer effective component combination
quality evaluation
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1544982/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1544982/full

Similar Items